November 26, 2012
The Ministry of Health, Labor and Welfare (MHLW) approved on November 21 additional indications for three active pharmaceutical ingredients (APIs)/five products, including GlaxoSmithKline’s Botox Injections 50 and 100 (botulinum toxin type A). These five products were recommended for approval at...read more